If you have spent any time buying sunscreen from Korean or Japanese retailers, you already know the thing this article is about, even if you do not know why it is true. The textures are better. The finishes are better. The cast is smaller or absent. And a great deal of the internet will tell you this is because Asian beauty brands are simply more sophisticated formulators, which is partly true and mostly beside the point.
The actual reason is a list of ingredients they are allowed to use and American manufacturers are not.
Until this June, the United States had gone since 1999 without adding a single new ultraviolet filter to its over-the-counter monograph. Twenty-seven years. In that window the European Union, Japan, Korea and Australia approved filters that do the job with less weight, less white, better photostability and broader coverage, and American formulators watched from behind glass.
On 9 June 2026, that changed: the FDA approved bemotrizinol — you may know it as Tinosorb S — as generally recognized as safe and effective at up to 6 percent, for adults and children from six months. First new filter in a quarter century.
One. There are seven or eight more in the queue.
Where the choice actually differs
| Approved UV filters | United States | Japan |
|---|---|---|
| Total filters available to formulators | 17, as of mid-2026 | 35 |
| Most recent addition before 2026 | 1999 | Ongoing |
| Regulatory class | Over-the-counter drug, monograph system | Quasi-drug, separate approval pathway |
| Bisoctrizole (Tinosorb M) | Not approved | Approved at 10% |
| DHHB (Uvinul A Plus) | Not approved | Approved at 10% |
| Drometrizole trisiloxane (Mexoryl XL) | Not approved | Approved at 15% |
What changes the answer: The EU has 29, Korea has 32, Australia has 28. The US monograph remains the most restrictive of the major regulated markets even after June's approval.
American sunscreens are as good as anyone else's.
- Source
- FDA over-the-counter sunscreen monograph; administrative order approving bemotrizinol, 9 June 2026
- Participants
- 17 approved UV filters in the US
- Measured
- Filters submitted through the US monograph and, since 2020, the CARES Act administrative order process
- Not measured
- Bisoctrizole, DHHB, drometrizole trisiloxane, ethylhexyl triazone, iscotrizinol — approved across the EU, Japan, Korea and Australia and not here
The EU has 29 filters, Korea 32, Japan 35, Australia 28. The gap is regulatory, not formulary skill, and it lands hardest on anyone for whom a mineral formula casts.
Why it took twenty-five years
Not because anybody decided the filters were dangerous. Because of the machinery.
The FDA’s monograph system ran on notice-and-comment rulemaking, which is slow in a way that is difficult to convey to anyone who has not watched a federal rule move. In 2014 Congress noticed and passed the Sunscreen Innovation Act, explicitly to create an expedited review pathway for new filters.
The Sunscreen Innovation Act produced zero approvals. Eight filters submitted under it were still sitting unapproved more than a decade later, reportedly stalled in part because the agency wanted Maximum Usage Trial data on terms that did not line up with international standards. So the filters had decades of European safety data and use history, and the wrong paperwork.
What finally moved bemotrizinol was not the law written to move it. It was the CARES Act of 2020 — the pandemic relief package — which happened to contain a provision replacing monograph rulemaking with a user-fee-funded administrative order process. That same provision is the one that took over-the-counter hydroquinone off the shelves, which is a strange pair of consequences for a single piece of legislation and a decent illustration of how American cosmetic regulation actually works.
What this has to do with skin that is not pale
Everything, and here is where I stop being amused by the bureaucracy.
The white cast problem is a formulation problem. Zinc oxide and titanium dioxide are opaque white particulates; the larger the particle, the more visible light it scatters, which is what leaves a gray-lavender film on brown skin and a chalky one on deep skin. Shrink the particles and the cast improves — and the visible-light protection drops, which matters a great deal if you are one of the people for whom visible light, not ultraviolet, is the wavelength range driving your pigment problem.
Modern organic filters relieve that pressure. They are colorless, they carry more of the UV load, and they let a formulator use less mineral to hit the same SPF — or spend the mineral budget on iron oxides instead, which are the pigments that actually block visible light.
So the twenty-five-year drought was not an inconvenience distributed evenly. A fair-skinned buyer in the US could always find an acceptable sunscreen; the cast was invisible on her. Everyone else got a choice between a chemical formula with a narrower filter set, a mineral formula that made them look ashy, or an import with a customs risk and no recourse if the shipment sat in a hot warehouse.
That is a regulatory failure with a demographic shape, and I have never once seen it described that way in the coverage of the FDA’s sunscreen delays.
What changes now
Less than the headline suggests, in the short term. An approval is not a product; reformulation, stability testing and manufacturing take time, and the first American bemotrizinol products will arrive quietly and cost more than they should. The other filters in the queue are still in the queue.
What I would not do is treat June as a reason to stockpile imports in a panic or to assume the shelf has already improved. What I would do is start reading the active ingredients panel on American sunscreens again in about a year, because for the first time since 1999 there is a reason to.
Twenty-five years is a long time to be told the problem was your skin.
Evidence check: Strong
Evidence level: regulatory fact, verifiable against the monograph and the June 2026 administrative order.
Sources reviewed September 13, 2026: FDA administrative order approving bemotrizinol, 9 June 2026, reported in JAAD International, 16 June 2026. Sunscreen Innovation Act, 2014. CARES Act, 2020, replacing monograph rulemaking with an administrative order process. Ten-country comparison of approved UV filters, 2026, cross-referenced against EU, Japanese, Korean and Australian regulatory listings.
This article is educational and is not a substitute for care from someone who can look at your skin. Anything new, changing, painful or spreading should be assessed rather than researched.
